Carl Zeiss Meditec AG (AFX.DE)

100,30 +1,30 (+1,31%) Börsenschluss: 05:35PM CEST

Carl Zeiss Meditec AG

Goschwitzer Strasse 51-52
Jena 07745
Germany
49 3641 220 115
https://www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 4.823

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Markus Weber	CEO & Chairman of Management Board	905,4k	N/A	N/A
Mr. Justus Felix Wehmer	CFO & Member of the Management Board	609,4k	N/A	1965
Dr. Christian Munster	Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board	N/A	N/A	1971
Stefanie Spanagel	Chief Operating Officer	N/A	N/A	N/A
Mr. Sebastian Frericks	Director of Investor Relations	N/A	N/A	N/A
Eva-Maria Heine	Chief Human Resources Officer	N/A	N/A	N/A
Mr. Steven C. Schallhorn M.D.	Chief Medical Officer for Global Ophthalmic Devices	N/A	N/A	N/A
Mr. Andrew Chang	Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.	N/A	N/A	N/A
Dr. Euan S. Thomson Ph.D.	President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit	N/A	N/A	1963
Mr. Magnus Reibenspiess	Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Corporate Governance

Carl Zeiss Meditec AGs ISS Governance QualityScore, Stand 1. April 2024, lautet 8. Die grundlegenden Scores sind Audit: 4, Vorstand: 7, Shareholderrechte: 6, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.